These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10938412

  • 1. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.
    Mahfouz MM, Kummerow FA.
    Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412
    [Abstract] [Full Text] [Related]

  • 2. Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets.
    Mahfouz MM, Kummerow FA.
    Prostaglandins Other Lipid Mediat; 1998 Jul; 56(4):197-217. PubMed ID: 9777653
    [Abstract] [Full Text] [Related]

  • 3. Oxidized low density lipoprotein inhibits prostacyclin generation by rat aorta in vitro: a key role of lysolecithin.
    Mahfouz M, Kummerow F.
    Prostaglandins Other Lipid Mediat; 2001 Dec; 66(4):283-304. PubMed ID: 11785781
    [Abstract] [Full Text] [Related]

  • 4. High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro.
    Mahfouz MM, Kummerow FA.
    Prostaglandins Other Lipid Mediat; 2003 Nov; 72(3-4):91-114. PubMed ID: 14674623
    [Abstract] [Full Text] [Related]

  • 5. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein.
    Martens JS, Lougheed M, Gómez-Muñoz A, Steinbrecher UP.
    J Biol Chem; 1999 Apr 16; 274(16):10903-10. PubMed ID: 10196168
    [Abstract] [Full Text] [Related]

  • 6. Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release.
    Needleman SW, Spector AA, Hoak JC.
    Prostaglandins; 1982 Nov 16; 24(5):607-22. PubMed ID: 6819602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase.
    Yuan Y, Schoenwaelder SM, Salem HH, Jackson SP.
    J Biol Chem; 1996 Oct 25; 271(43):27090-8. PubMed ID: 8900200
    [Abstract] [Full Text] [Related]

  • 9. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
    Koba S, Pakala R, Watanabe T, Katagiri T, Benedict CR.
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec 25; 63(6):329-35. PubMed ID: 11133169
    [Abstract] [Full Text] [Related]

  • 10. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 25; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 11. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR, Loo G.
    J Pineal Res; 1997 May 25; 22(4):203-9. PubMed ID: 9247205
    [Abstract] [Full Text] [Related]

  • 12. Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.
    Chou DS, Hsiao G, Shen MY, Fong TH, Lin CH, Chen TF, Sheu JR.
    Lipids; 2004 May 25; 39(5):433-40. PubMed ID: 15506238
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoproteins supply phospholipid-bound arachidonic acid for platelet eicosanoid production.
    Dobner P, Engelmann B.
    Am J Physiol; 1998 Nov 25; 275(5):E777-84. PubMed ID: 9814996
    [Abstract] [Full Text] [Related]

  • 14. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
    Korotaeva AA, Cheglakov IB, Morozkin AD, Suslova IV, Prokazova NV.
    Membr Cell Biol; 1997 Nov 25; 10(5):521-34. PubMed ID: 9225256
    [Abstract] [Full Text] [Related]

  • 15. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein.
    Alexander JJ, Lewis I.
    J Surg Res; 2002 Mar 25; 103(1):41-6. PubMed ID: 11855916
    [Abstract] [Full Text] [Related]

  • 16. Cell-cell interaction between platelets and IL-1 beta-stimulated vascular smooth muscle cells in synthesis of thromboxane A2.
    Zou M, Anges C.
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb 25; 56(2):85-91. PubMed ID: 9051715
    [Abstract] [Full Text] [Related]

  • 17. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 25; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 18. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E, Furman C, Fouquet S, Martin-Nizard F, Lestavel S, Gozzo A, Lesieur D, Fruchart JC, Duriez P, Teissier E.
    J Cardiovasc Pharmacol; 1998 Oct 25; 32(4):582-92. PubMed ID: 9781926
    [Abstract] [Full Text] [Related]

  • 19. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages.
    Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S.
    J Biol Chem; 1994 Dec 16; 269(50):31430-5. PubMed ID: 7989310
    [Abstract] [Full Text] [Related]

  • 20. Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.
    Sonoki K, Iwase M, Iino K, Ichikawa K, Ohdo S, Higuchi S, Yoshinari M, Iida M.
    Metabolism; 2003 Mar 16; 52(3):308-14. PubMed ID: 12647268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.